display:none
Skip to main content

Digital Medicine Academy®️ Licenses for Organizations

Give your whole team a common understanding of the digitization of healthcare.

Did you know?

In 2019, the EMA qualified the SV95C digital endpoint for use in pivotal and exploratory drug therapeutics studies for ambulant Duchenne Muscular Dystrophy (DMD) patients?

Let us help you optimize your next study.

Avaliable Courses

Online Course

Fast Track to Digital Clinical Trials for Pharma

Give your team a common understanding of healthcare digitization that is customizable for your team with unlimited users.

SCHEDULE TIME WITH OUR TEAM
Digital Medicine Academy course logo--an image of a laptop with a motorboard surrounded by the course name "Fast Track to Digital Clinical Trials For Pharma"

Earn a Credly Badge

Once you complete a course, you’ll receive digital credentials to showcase your professional development in the digital healthcare field.
  • Share your proof of achievements on social media
  • Provides recognition for acquiring new skills
  • Allows hiring managers to easily see acquired competencies

What to Expect from DiMe Academy®️

What sets us apart is why we’re known as the most trusted name in digital health innovation globally.

Engaging Courses

Interactive sessions cater to a variety of learning styles with videos, knowledge checks to test your understanding, and real-world examples.

Flexible Learning

You’re busy, and so is your team, so our courses are designed to deliver the material efficiently, but our platform is designed so you can return as many times as you need.

Relevant Content

Digital medicine is a fast paced field. We leverage our community to deliver up to date information from actively engaged, diverse experts.

Want a tailored course package?

Contact us to learn how to create a Digital Medicine Academy course package tailored to your organization!

DiMe in the News

Recent articles discussing the current landscape in digital medicine

Join our next project

Help streamline the path to regulatory and commercial success to optimize health outcomes for the greatest number of patients

Join the Integrated Evidence Plans project

Join us
Not today